The stent is developed by Abbott Laboratories and made of a degradable material that dissipates much like stitches after a year for patients who have had their arteries cleared of plaque. The new device could be a good alternative to metal stents, which in rare instances break and cause serious complications.
Although trials of the new stent haven’t produced statistically significant improvements in patient outcomes, the device could receive FDA approval by year’s end.
More articles on quality:
Patent application suggests Apple Watch could become medical device
Physicians call on Congress to crack down on wound care product managers
Study: Disruptive patients more likely to receive misdiagnosis
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
